| Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species FJ Prado-Prado, X García-Mera, H González-Díaz Bioorganic & medicinal chemistry 18 (6), 2225-2231, 2010 | 157 | 2010 |
| MIND-BEST: Web Server for Drugs and Target Discovery; Design, Synthesis, and Assay of MAO-B Inhibitors and Theoretical− Experimental Study of G3PDH Protein from Trichomonas … H González-Díaz, F Prado-Prado, X García-Mera, N Alonso, P Abeijón, ... Journal of proteome research 10 (4), 1698-1718, 2011 | 108 | 2011 |
| Synthesis and QSAR study of the anticancer activity of some novel indane carbocyclic nucleosides SW Yao, VHC Lopes, F Fernández, X Garcıa-Mera, M Morales, ... Bioorganic & medicinal chemistry 11 (23), 4999-5006, 2003 | 95 | 2003 |
| Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists A Crespo, A El Maatougui, P Biagini, J Azuaje, A Coelho, J Brea, MI Loza, ... ACS Medicinal Chemistry Letters 4 (11), 1031-1036, 2013 | 82 | 2013 |
| Pyrimidine Derivatives as Potent and Selective A3 Adenosine Receptor Antagonists V Yaziji, D Rodriguez, H Gutiérrez-de-Terán, A Coelho, O Caamano, ... Journal of medicinal chemistry 54 (2), 457-471, 2011 | 77 | 2011 |
| Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives FJ Romero-Duran, N Alonso, M Yanez, O Caamano, X García-Mera, ... Neuropharmacology 103, 270-278, 2016 | 74 | 2016 |
| ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen E Tenorio-Borroto, CGP Rivas, JCV Chagoyán, N Castañedo, ... Bioorganic & medicinal chemistry 20 (20), 6181-6194, 2012 | 74 | 2012 |
| Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes A El Maatougui, J Azuaje, M Gonzalez-Gomez, G Miguez, A Crespo, ... Journal of medicinal chemistry 59 (5), 1967-1983, 2016 | 73 | 2016 |
| Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica F Prado-Prado, X García-Mera, P Abeijón, N Alonso, O Caamaño, ... European journal of medicinal chemistry 46 (4), 1074-1094, 2011 | 73 | 2011 |
| TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1, 3-rasagiline derivatives potentially useful in neurodegenerative … F Luan, MNDS Cordeiro, N Alonso, X García-Mera, O Caamaño, ... Bioorganic & medicinal chemistry 21 (7), 1870-1879, 2013 | 72 | 2013 |
| 2D MI-DRAGON: a new predictor for protein–ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human … F Prado-Prado, X García-Mera, M Escobar, E Sobarzo-Sánchez, M Yañez, ... European journal of medicinal chemistry 46 (12), 5838-5851, 2011 | 69 | 2011 |
| Studies on olefin epoxidation with t-BuOOH catalysed by dioxomolybdenum (VI) complexes of a novel chiral pyridyl alcoholate ligand AA Valente, IS Gonçalves, AD Lopes, JE Rodríguez-Borges, M Pillinger, ... New Journal of Chemistry 25 (7), 959-963, 2001 | 66 | 2001 |
| Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates N Alonso, O Caamano, FJ Romero-Duran, F Luan, MN DS Cordeiro, ... ACS chemical neuroscience 4 (10), 1393-1403, 2013 | 65 | 2013 |
| NL MIND-BEST: A web server for ligands and proteins discovery—Theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum H González-Díaz, F Prado-Prado, E Sobarzo-Sánchez, M Haddad, ... Journal of theoretical biology 276 (1), 229-249, 2011 | 56 | 2011 |
| Entropy model for multiplex drug-target interaction endpoints of drug immunotoxicity E Tenorio-Borroto, X Garcia-Mera, C G. Penuelas-Rivas, ... Current topics in medicinal chemistry 13 (14), 1636-1649, 2013 | 48 | 2013 |
| Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide … J Ferreira da Costa, D Silva, O Caamaño, JM Brea, MI Loza, ... ACS Chemical Neuroscience 9 (11), 2572-2587, 2018 | 46 | 2018 |
| Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set A Morales Helguera, JE Rodriguez-Borges, X García-Mera, F Fernández, ... Journal of medicinal chemistry 50 (7), 1537-1545, 2007 | 45 | 2007 |
| Model for high-throughput screening of drug immunotoxicity–study of the anti-microbial G1 over peritoneal macrophages using flow cytometry E Tenorio-Borroto, CG Penuelas-Rivas, JC Vasquez-Chagoyan, ... European Journal of Medicinal Chemistry 72, 206-220, 2014 | 43 | 2014 |
| Entropy multi-target QSAR model for prediction of antiviral drug complex networks FJ Prado-Prado, I García, X García-Mera, H González-Díaz Chemometrics and Intelligent Laboratory Systems 107 (2), 227-233, 2011 | 43 | 2011 |
| Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1, 2-rasagiline carbamates FJ Romero Duran, N Alonso, O Caamaño, X García-Mera, M Yañez, ... International journal of molecular sciences 15 (9), 17035-17064, 2014 | 39 | 2014 |
Olga Caamaño SantosTitular Química Organica, Universidad de Santiago de CompostelaDirección de correo verificada de usc.es
